Screener
Sabra Healthcare SBRA Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001492298-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Non-cash rental and related revenues | (1,599) | (2,428) |
| Non-cash interest income | — | 4 |
| Non-cash interest expense | 2,368 | 1,729 |
| Stock-based compensation expense | 3,098 | 2,711 |
| Recovery of loan losses | (213) | (173) |
| Impairment of real estate | 440 | — |
| Income from unconsolidated joint ventures | (1,912) | (218) |
| Distributions of earnings from unconsolidated joint ventures | 1,657 | 2,368 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Sabra Healthcare's stock-based comp?
- Sabra Healthcare (SBRA) reported stock-based comp of $3.1M in Q1 2026.
- How has Sabra Healthcare's stock-based comp changed year-over-year?
- Sabra Healthcare's stock-based comp increased by 14.3% year-over-year, from $2.71M to $3.1M.
- What is the long-term trend for Sabra Healthcare's stock-based comp?
- Over 4 years (2021 to 2025), Sabra Healthcare's stock-based comp has grown at a 9.5% compound annual growth rate (CAGR), from $7.91M to $11.36M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Sabra Healthcare's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude